Clinical Trial Update: Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating the radiopharmaceutical 99mTc-rBitistatin for imaging venous thrombosis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thrombosis

Drugs mentioned

• 99mTc-rBitistatin (rBitistatin)

Snippet

Sponsor: Temple University | Conditions: Venous Thrombosis | Phase 1, Phase 2 | Status: WITHDRAWN